Sowell Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-85
Closed – – 3197
2021
Q1
$0 Hold
85
– – ﹤0.01% 3442
2020
Q4
$0 Hold
85
– – ﹤0.01% 2964
2020
Q3
$0 Hold
85
– – ﹤0.01% 2830
2020
Q2
$0 Hold
85
– – ﹤0.01% 2806
2020
Q1
$0 Sell
85
-364
-81% -$1.17K ﹤0.01% 2848
2019
Q4
$1K Buy
449
+364
+428% +$1.06K ﹤0.01% 2488
2019
Q3
$0 Buy
+85
New +$227 ﹤0.01% 2504

Other funds holding PDLI

Sowell Financial Services's PDLI Position: Q2 2021 in Review

Sowell Financial Services sold out of PDL BioPharma, Inc. (PDLI) in Q2 2021, closing a stake of 85 shares.

Sowell Financial Services first reported a position in PDLI in Q3 2019 and held it in 7 quarters. The position peaked at $1K in Q4 2019. 8 funds tracked by Wall St. Rank hold PDLI as of Q2 2021.

  • Sowell Financial Services reported no remaining PDL BioPharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 85 PDL BioPharma, Inc. shares in Q2 2021.
  • Sowell Financial Services first reported a position in PDL BioPharma, Inc. in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's PDL BioPharma, Inc. position peaked at $1K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.